For the Inventor, By the Inventor

Enter assignee name

Radebeul, Germany

Arzneimittelwerk Dresden Gmbh

USPTO Granted Patents = 39

% Expired Patents = 12.8

CIPO Patents = 1

Forward Citations = 204

Loading Chart...

Loading Chart...

107 inventors (with patents filed for the assignee):

Hildegard Poppe (11 out of 15 patents)

Dieter Lohmann (7 out of 9 patents)

Norbert Höfgen (7 out of 8 patents)

4. Reni Bartsch (7 out of 10 patents)

5. Ute Egerland (6 out of 22 patents)

6. Klaus Unverferth (6 out of 10 patents)

7. Degenhard Marx (6 out of 12 patents)

8. Thomas Kronbach (6 out of 12 patents)

9. Stefan Szelényi (6 out of 6 patents)

10. Sabine Heer (6 out of 10 patents)

11. Angelika Rostock (6 out of 9 patents)

12. Emmanuel Polymeropoulos (5 out of 24 patents)

13. Rudolf Schindler (4 out of 12 patents)

14. Hans-Joachim Lankau (4 out of 14 patents)

15. Gottfried Faust (4 out of 5 patents)

39 patents: Sort by Forward Citations

1. 6613794 - Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation (2003-09-02),

2. 6602890 - Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation (2003-08-05),

3. 6545158 - Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation (2003-04-08),

4. 6545025 - Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation (2003-04-08),

5. 6500821 - 4-amino-1-aryl-1,5-dihydropyrrol-2-ones and process for making (2002-12-31),

6. 6472165 - Modulatory binding site in potassium channels for screening and finding new active ingredients (2002-10-29),

7. 6465465 - Process for the treatment of erectile dysfunction and product therefor (2002-10-15),

8. 6306306 - Chromatographic process for obtaining highly purified cyclosporin A and related cyclosporins (2001-10-23),

9. 6251923 - Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparation (2001-06-26),

10. 6242002 - Effervescent formulations (2001-06-05),

11. 6180637 - 1,2,5-trisubstituted 1,2-dihydroindazol-3-ones having anti-asthmatic, anti-allergic, anti-inflammatory, immunomodulating and neuroprotective action, process for their preparation and their use as medicaments (2001-01-30),

12. 6166023 - 1,5- and 3-O-substituted 1H-indazoles having anti-asthmatic, (2000-12-25),

13. 616602 - 1,5- and 3-O-substituted 1H-indazoles having anti-asthmatic, (2000-12-26),

14. 6143795 - Stable mitoxantrone solutions (2000-11-07),

15. 6103264 - Process for preparing a controlled release composition (2000-08-15),

Arzneimittelwerk Dresden is a pharmaceutical company located in Dresden, Germany. With over 120 years of experience, they specialize in the development, production, and distribution of a wide range of pharmaceutical products. Their commitment to quality, innovation, and customer satisfaction has made them a trusted partner in the healthcare industry. For more information, please visit their website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 8 2026

39 Patents

#1 in Radebeul

#1,297 in Germany

#17,372 in the World

Radebeul, Germany

Arzneimittelwerk Dresden Gmbh

Forward Citations = 204

107 inventors:

Hildegard Poppe (11 out of 15 patents)

Dieter Lohmann (7 out of 9 patents)

Norbert Höfgen (7 out of 8 patents)

4. Reni Bartsch (7 out of 10 patents)

5. Ute Egerland (6 out of 22 patents)

Please report any incorrect information to [email protected]

Loading…